Association of Antigen-Stimulated Release of Tumor Necrosis Factor-Alpha in Whole Blood with Response to Chemotherapy in Patients with Pulmonary Multidrug-Resistant Tuberculosis
- 10 February 2010
- journal article
- research article
- Published by S. Karger AG in Respiration
- Vol. 80 (4), 275-284
- https://doi.org/10.1159/000283687
Abstract
Background: We have previously reported that TNF-α levels correlate to total mycobacterial burden in tuberculosis (TB) patients. Objective: To characterize the dynamics of cytokine responses in TB patients during chemotherapy to identify potential surrogate markers for effective treatment. Methods: Following induction by culture filtrate proteins in whole blood, production patterns of TNF-α, IL-10, IFN-γ and IL-12 were measured in 23 non-multidrug-resistant (MDR)-TB and 16 MDR-TB patients and in 31 healthy controls. Rates of mycobacterial clearance from the sputum were then measured and compared. Results: Prior to the initiation of chemotherapy, TNF-α and IL-10 levels were significantly higher in TB patients than in healthy controls while IFN-γ and IL-12 levels were similar. During chemotherapy, the levels of all 4 cytokines increased. We evaluated these responses separately in patients that did and did not clear their sputum culture at 2 and 6 months. At 2 months, decreases in both IFN-γ and IL-12 correlated strongly with a successful early response, while after 6 months of therapy, when half (7/14) of MDR-TB patients were still sputum culture positive, downregulation of TNF-α was uniquely correlated with sputum conversion between the groups. Conclusion: Our findings suggest the possibility that the regulation of TNF-α production in whole blood may be a more specific indicator of sputum conversion at 6 months than IFN-γ, IL-12 or IL-10 in MDR-TB patients.Keywords
This publication has 22 references indexed in Scilit:
- Tumor Necrosis Factor-Alpha and Interleukin-10 in Whole Blood Is Associated with Disease Progression in Pulmonary Mulitdrug-Resistant Tuberculosis PatientsRespiration, 2008
- Sputum Cytokine Levels in Patients with Pulmonary Tuberculosis as Early Markers of Mycobacterial ClearanceClinical and Vaccine Immunology, 2002
- Profiles of IFN-γand its regulatory cytokines (IL-12, IL-18 and IL-10) in peripheral blood mononuclear cells from patients with multidrug-resistant tuberculosisClinical and Experimental Immunology, 2002
- Cytokine profiles using whole-blood assays can discriminate between tuberculosis patients and healthy endemic controls in a BCG-vaccinated populationJournal of Immunological Methods, 2002
- Immunology of TuberculosisAnnual Review of Immunology, 2001
- Revised international definitions in tuberculosis control.2001
- Correlates of Protective Immunity to Mycobacterium tuberculosis in HumansClinical Infectious Diseases, 2000
- Clinical Correlates of Interferon Production in Patients with TuberculosisClinical Infectious Diseases, 1997
- Interleukin 12 (IL-12) Is Crucial to the Development of Protective Immunity in Mice Intravenously Infected with Mycobacterium tuberculosisThe Journal of Experimental Medicine, 1997
- Th1/Th2 profiles in tuberculosis, based on the proliferation and cytokine response of blood lymphocytes to mycobacterial antigens.1994